Q1 2023 Trinity Biotech PLC Earnings Call Transcript
Hello and welcome to the Trinity Biotech first quarter fiscal year 2023 financial results. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Joe Diaz with Lytham Partners. Please go ahead.
Thank you, MJ, and thanks to all of you for joining us today to review the financial results of Trinity Biotech for the first quarter of 2023. Joining us on today's call are Aris Kekedjian, Chief Executive Officer, and John Gillard, Chief Financial Officer. At the conclusion of today's prepared remarks, we will open the call for a question-and-answer session. Before we begin, please note that statements made during this conference call may be deemed forward-looking statements within the meaning of the federal securities laws. These statements are not subject to known and unknown risks and uncertainties that may cause actual results to differ from those expressed or implied in such statements.
These risks include but are not limited to those set forth in the risk factors
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |